SPY299.08+3.64 1.23%
DIA250.25+5.37 2.19%
IXIC9,340.22+15.63 0.17%

UBS Maintains Buy on CVS Health, Lowers Price Target to $79

UBS maintains CVS Health (NYSE:CVS) with a Buy and lowers the price target from $85 to $79.

Benzinga · 05/07/2020 16:24

UBS maintains CVS Health (NYSE:CVS) with a Buy and lowers the price target from $85 to $79.